A rheumatologist with a background in biostatistics, data science & bioinformatics discusses the use of artificial intelligence in clinical research.
ACR President Warns: Access to Care Is at Risk Without Medicare Payment Reform
In a recent commentary published by Medscape, ACR President Carol Langford, MD, MHS, issues a stark warning: If Congress does not reform the physician payment system, patients may face increasing difficulty accessing essential medical services.
ACR Responds to Threats to Scientific Integrity at the CDC
On Aug. 29, the ACR issued a strong statement expressing deep concern over recent developments at the agency that could threaten the integrity of science-based public health policy.
Celebrating Interdisciplinary Collaboration: Pathways to Success
Four past ARP presidents mark the organization’s 60th anniversary by examining its evolution alongside significant challenges & opportunities in the field.
Rheum for Everyone, Who Am I? Episode 23 (video)
In this episode, Dr. Kumar talks about the fascinating and intriguing secret lives of rheumatologists—real life superheroes.
Cardiovascular Risks Similar for JAK Inhibitors & bDMARDs
Using data from registries across Europe and Canada, Aymon et al. compared the incidence of major adverse cardiac events (MACE) in patients with RA treated with JAK inhibitors, TNF inhibitors or biologic DMARDs with other modes of action over two years. The researchers did not find an increased risk of MACE with JAK inhibitors over that time frame.
Mouth-Watering Possibilities in Sjögren’s Disease
New ACR guidelines for SARD-associated interstitial lung disease cover key recommendations for screening, monitoring and first-line treatment options.
Sjögren’s Disease: More Than Just a Syndrome
A EULAR 2025 review of Sjögren’s disease covered new pathogenic insights & promising phase 2 data for BTK inhibitors & CD40 pathway drugs.
How to Diagnose Sjögren’s Disease
Improve your Sjögren’s disease diagnosis. Experts discuss objective testing, seronegative cases, ILD screening & management strategies.
How the Experts Treat Sjögren’s Disease
With no FDA-approved drugs for Sjögren’s disease, experts share strategies for managing fatigue, arthritis, dryness, and systemic issues.
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 830
- Next Page »